Global report - February 22, 2023
First gene therapy for hemophilia B approved in the EU
The European Commission has granted conditional marketing authorization (CMA) for CSL’s HEMGENIX, the first and only one-time gene therapy for the treatment of severe and moderately severe hemophilia B in adults without a history of Factor IX inhibitors. In the ongoing clinical trial, HEMGENIX reduced the rate of annual bleeds with a single infusion by delivering […]
Global report - October 29, 2022
NLS Insight: Circadian rhythms
This weekend most countries in Europe will spring backward one hour. We take a closer look upon how our inner clock regulates critical functions like behavior, hormone levels, sleep, body temperature and metabolism. Daylight Saving Time (DST) is not removed in 2022 despite the fact that the European Parliament voted to end daylight saving time in […]
Global report - October 7, 2022
Substandard paediatric medicines linked to 66 child deaths
The World Health Organization (WHO) has made a Medical Product Alert that refers to four substandard (contaminated) products, identified in The Gambia and reported to WHO in September 2022. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. The stated manufacturer of these products […]
Careers - September 28, 2022
“Although the war has affected me a lot, I will not lose heart!”
Hello, my name is Anatolii Kovalchuk, and I am a remote developer from Ukraine. This is the story of my experience working for a European startup during the war. My remote working path as a back-end developer for the Danish life science company Knowledge Gate Group began a few months after the full scale invasion […]
Global report - June 29, 2022
BIO Bounces Back
Straight after ASCO, BIO 2022 was back in person in San Diego, June 13-17. Some 15,000 delegates from around the world attended. The exhibition hall was packed with national and regional pavilions from every country with skin in the life science game (except, surprisingly and controversially, the UK) and the special biomanufacturing area has grown […]
Global report - May 31, 2022
Pfizer launches “An Accord for a Healthier World”
This initiative aims to provide all of Pfizer’s patented medicines and vaccines available in the US or the European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries. The Accord seeks to greatly reduce the health inequities that exist between many lower-income countries and the rest of the world, Pfizer states. […]
